About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Israeli opposition leader Yair Lapid said the opposition must form a government and remove Benjamin Netanyahu from the prime minister's office.

2026-11-03

Israeli opposition leader Yair Lapid said the opposition must form a government and remove Benjamin Netanyahu from the prime minister's office.

Other News
2026-11-03

New Zealand's building permits fell 7.9% month-on-month in September, with the previous figure revised from 5.60% to 5.3%.

New Zealand's building permits fell 7.9% month-on-month in September, with the previous figure revised from 5.60% to 5.3%.
2026-11-03

Individual Stock News 1. Xizhi Technology-P (01879.HK) entered into a tutoring agreement for its A-share listing. 2. Tianshu Zhixin (09903.HK) reported cumulative chip shipments exceeding 80,000 units in the first 10 months. 3. Shenyan Intelligent

Individual Stock News 1. Xizhi Technology-P (01879.HK) entered into a tutoring agreement for its A-share listing. 2. Tianshu Zhixin (09903.HK) reported cumulative chip shipments exceeding 80,000 units in the first 10 months. 3. Shenyan Intelligent (02723.HK) signed a strategic cooperation agreement with Baidu Smart Cloud to jointly promote integrated AI decision-making solutions. 4. Yingde Holdings (08535.HK) saw a change of controlling stake, with the acquiring company offering a full takeover bid at a discount of approximately 86.79%. Trading resumed on November 3. 5. Simcere Pharmaceutical (02096.HK) entered into an exclusive promotion service agreement with Lingke Pharmaceutical for the dermabrasion indication of zepxitinib. 6. Hengtai (00197.HK) announced its annual results: a net loss of approximately HK$232 million, a year-on-year increase of 13.3%. Trading resumed on November 3. 7. Hanteng Technology (02726.HK) issued a profit warning: Net profit for fiscal year 2026 is expected to be approximately RMB 108 million to RMB 158 million, representing a year-on-year increase of approximately 800% to 1217%. 8. Ingdan Innovation (00400.HK): For the three months ended September 30, 2026, the Group recorded revenue of approximately RMB 7.667 billion, an increase of approximately 130.1% compared to the same period in 2025. 9. CSPC Pharmaceutical Group (01093.HK): Positive top-line results were obtained from the Phase III clinical trial of pruluvilipin tablets in combination with dapagliflozin tablets and metformin hydrochloride extended-release tablets for the treatment of type 2 diabetes.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.